Search Results - naser+hoti

1 Results

Sort By:

Host Defense Turned Viral Offense; Engineering the Next Generation of Oncolytic Adenoviruses

C10910: Use of RNA Interference and Adenovirus Therapy against Prostate CancerValue Proposition: • Addresses a major patient need • Enhances the therapeutic efficacy of CRAd strategy • Creates the bases to develop enhanced oncolytic viral gene therapies with shRNA Technical Details: Prostate cancer is one of the most aggressive cancers...

Published: 3/13/2025 | Inventor(s): Naser Hoti, Ronald Rodriguez

Keywords(s): Biologics, Cancers, Cell Therapy/Immunotherapy, Combination, Disease Indication, Drug Delivery Vehicle, Nucleic Acid, Plasmid/Vector, Prostate Cancer, Therapeutic Matter, Therapeutic Substance, Therapeutics, Therapy Type

Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Men's Health, Clinical and Disease Specializations > Oncology > Prostate Cancer, Technology Classifications > Therapeutic Modalities > Biologics, Technology Classifications > Therapeutic Modalities > Cell Therapies, Technology Classifications > Therapeutic Modalities > Gene Therapies, Technology Classifications > Therapeutic Modalities > Immunotherapies, Technology Classifications > Therapeutic Modalities > Therapeutic Delivery Platforms, Clinical and Disease Specializations > Oncology, Technology Classifications > Therapeutic Modalities